Physician profile
William E Hanks
NPI 1609845189
$5,909.38
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,851 · 2020: $1,113 · 2021: $1,387 · 2022: $559.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,274.22 | 2019-2022 | |
| Abiomed | $544.80 | 2019-2021 | |
| Amarin Pharma, INC. | $439.98 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $396.38 | 2019-2022 | |
| Elutia, INC. | $394.14 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $332.34 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $285.41 | 2019-2022 | |
| Shockwave Medical, INC | $248.04 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $223.32 | 2019-2022 | |
| Medtronic, INC. | $218.56 | 2021-2022 | |
| Pfizer INC. | $206.98 | 2019-2021 | |
| Edwards Lifesciences Corporation | $171.23 | 2021 | |
| Janssen Pharmaceuticals, INC | $169.95 | 2019-2021 | |
| Akcea Therapeutics, INC. | $165.61 | 2019-2020 | |
| Biotronik INC. | $135.92 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $132.98 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $124.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.97 | 2019-2021 | |
| Medtronic Vascular, INC. | $59.36 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.07 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $41.95 | 2020-2022 | |
| Genzyme Corporation | $38.72 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $33.65 | 2022 | |
| Gilead Sciences, INC. | $31.47 | 2019 | |
| Cathworks, INC. | $20.92 | 2019 | |
| United Therapeutics Corporation | $17.31 | 2020 | |
| Philips North America LLC | $15.17 | 2020 | |
| Tactile Systems Technology INC | $14.79 | 2022 | |
| Lundbeck LLC | $14.62 | 2019 | |
| Lilly USA, LLC | $12.10 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.